Return to Home Mortality > Table > Interpret

Interpretation of Death Rates Data

Death Rate Report by State

Breast, 2023

All Races (includes Hispanic), Female, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Death Rate (95% Confidence Interval) - The death rate is based upon 100,000 people and is for 1 year(s). Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population (the Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal).

Recent Trends - This is an interpretation of the AAPC:

AAPC (95% Confidence Interval) - The Average Annual Percent Change is the change in rate over time. These AAPCs are based upon APCs that were calculated by Joinpoint Regression Program


Other Notes


Line by Line Interpretation of the Report


District of Columbia


Oklahoma


Mississippi


Tennessee


Georgia


Alabama


Nebraska


Kentucky


Delaware


West Virginia


Louisiana


South Carolina


Indiana


Ohio


Missouri


Utah


Texas


Nevada


New Mexico


North Carolina


Washington


Colorado


Oregon


Virginia


Arkansas


Montana


Kansas


Maryland


New Jersey


Wyoming


Florida


California


Pennsylvania


Idaho


Vermont


Michigan


Maine


New Hampshire


Illinois


Arizona


Minnesota


Alaska


Rhode Island


Wisconsin


North Dakota


Connecticut


Iowa


Hawaii


New York


Massachusetts


South Dakota


Puerto Rico





Notes:
Created by statecancerprofiles.cancer.gov on 03/24/2026 2:11 am.

State Cancer Registries may provide more current or more local data.

† Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (20 age groups: <1, 1-4, 5-9, ... , 80-84, 85-89, 90+).

Population counts for denominators are based on Census populations as modified by NCI.

The US Population Data File is used with mortality data.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.